Avelumab, niraparib and tivozanib are now listed in the interaction checker as cancer drugs and interactions can be found for all the comedications.
- Avelumab (Bavencio®) is a monoclonal antibody and is indicated for the treatment of Merkel cell carcinoma.
- Niraparib (Zejula®) is a PARP inhibitor and is indicated for the treatment of epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
- Tivozanib (Fotivda®) is a VEGFR1/2/3 inhibitor and is indicated for the treatment of renal cell carcinoma.
